25 July 2024 
Tybourne Capital Management, a global, growth-oriented, fundamental equity investor in public and private markets, recently participated in SkyCell AG's USD 116m Series D financing round. SkyCell, a Swiss technology company active in the pharmaceutical supply chain, plans to use the investment for the continued expansion of its global footprint with a key focus on growth across the Americas, EMEA, and Asia.
VISCHER advised Tybourne Capital Management in the transaction. The team included Dr. Matthias Staehelin (Partner, Corporate/M&A) and Luzius Zumstein (Managing Associate, Corporate/M&A).
Author: Matthias Staehelin
Matthias Staehelin
Attorney at Law and Civil Law Notary (BS/BL)
- Partner
- +41 58 211 33 53
- [email protected]